Holen Sie sich die Stockscreener-App
177.89
0.27%
0.57
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MASI?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$177.32
Offen:
$177.85
24-Stunden-Volumen:
854.37K
Relative Volume:
0.55
Marktkapitalisierung:
$9.29B
Einnahmen:
$1.53B
Nettoeinkommen (Verlust:
$207.70M
KGV:
-64.14
EPS:
-2.7734
Netto-Cashflow:
$193.10M
1W Leistung:
-0.50%
1M Leistung:
+1.40%
6M Leistung:
+20.50%
1J Leistung:
+6.72%
1-Tages-Spanne:
$176.94
$178.21
1-Wochen-Bereich:
$176.68
$178.77
52-Wochen-Spanne:
$125.94
$179.00
Masimo Corp Stock (MASI) Company Profile
Firmenname
Masimo Corp
Sektor
Branche
Telefon
949-297-7000
Adresse
52 DISCOVERY, IRVINE, CA
Compare MASI vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
177.86 | 9.26B | 1.53B | 207.70M | 193.10M | -2.7734 |
ABT
Abbott Laboratories
|
102.51 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.77 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.69 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.59 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-11-17 | Eingeleitet | BofA Securities | Neutral |
| 2024-12-27 | Bestätigt | Raymond James | Outperform |
| 2024-11-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-06-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-15 | Hochstufung | Stifel | Hold → Buy |
| 2024-03-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2024-01-03 | Herabstufung | Needham | Buy → Hold |
| 2023-11-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-07-18 | Herabstufung | Stifel | Buy → Hold |
| 2023-07-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-02-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-12-15 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-12-05 | Bestätigt | Needham | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-09-15 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-09-14 | Eingeleitet | Loop Capital | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-02-18 | Hochstufung | Needham | Hold → Buy |
| 2022-02-16 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-10-12 | Fortgesetzt | Raymond James | Mkt Perform |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-04-20 | Herabstufung | Needham | Buy → Hold |
| 2020-03-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-07 | Bestätigt | Needham | Buy |
| 2019-04-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-03-13 | Bestätigt | Needham | Buy |
| 2018-12-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-14 | Eingeleitet | Needham | Buy |
| 2018-03-09 | Eingeleitet | Barclays | Overweight |
| 2017-08-14 | Hochstufung | BTIG Research | Neutral → Buy |
| 2017-04-04 | Bestätigt | Wedbush | Outperform |
| 2017-03-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-02-27 | Bestätigt | Wedbush | Outperform |
| 2017-02-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2016-05-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2016-05-05 | Bestätigt | Wedbush | Outperform |
| 2016-01-06 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2015-08-05 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Masimo Corp Aktie (MASI) Neueste Nachrichten
Quinn Emanuel Disqualified from Masimo Board Fight with Founder - Bloomberg Law News
Masimo Corp Stock: Innovative Medical Tech Leader with Strong Growth Potential for North American In - AD HOC NEWS
Assenagon Asset Management S.A. Grows Stock Holdings in Masimo Corporation $MASI - MarketBeat
Masimo Corporation (NASDAQ:MASI) Short Interest Update - MarketBeat
Masimo Corp at JPMorgan Healthcare Conference Transcript - GuruFocus
Masimo Corp Stock Faces Uncertainty Amid Analyst Downgrade and Pending Danaher Acquisition Deal - AD HOC NEWS
Danaher to Acquire Masimo Diagnostics in $9.9B Deal - USA Herald
The Vanguard Group discloses 0 shares in Masimo Corp (NASDAQ: MASI) - Stock Titan
Masimo downgraded to Market Perform from Outperform at Raymond James - TipRanks
Masimo (NASDAQ:MASI) Rating Lowered to Market Perform at Raymond James Financial - MarketBeat
Raymond James downgrades Masimo stock rating on Danaher deal By Investing.com - Investing.com India
Masimo Corporation $MASI Shares Sold by JPMorgan Chase & Co. - MarketBeat
Raymond James downgrades Masimo stock rating on Danaher deal - Investing.com
Masimo Corporation (NASDAQ:MASI) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
MASI PE Ratio & Valuation, Is MASI Overvalued - Intellectia AI
Tudor Investment Corp ET AL Buys New Holdings in Masimo Corporation $MASI - MarketBeat
Masimo MightySat Medical Fingertip Pulse Oximeter: Precision Health Monitoring for Home and Clinical - AD HOC NEWS
Danaher said to near $10 billion deal for Masimo, FT reports - MSN
Masimo (NASDAQ:MASI) Reaches New 12-Month HighTime to Buy? - MarketBeat
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition - Yahoo Finance
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition - The Motley Fool
Masimo's Patient Monitoring Innovations Drive Growth in Wearable Health Tech for DACH Markets - AD HOC NEWS
Masimo's Latest Health Monitoring Receivers Advance Wearable Audio Integration for DACH Consumers - AD HOC NEWS
MASI Technical Analysis & Stock Price Forecast - Intellectia AI
Apple fends off bid for new Apple Watch import ban at US trade tribunal - Reuters
Masimo (NASDAQ:MASI) Upgraded at Wells Fargo & Company - MarketBeat
Apple Took Masimo IP But No Remedy Warranted, Judge Says - law360.com
Danaher to buy Masimo (MASI) for $180 a share; $305M breakup fee - Stock Titan
Masimo (NASDAQ:MASI) Sets New 52-Week HighShould You Buy? - MarketBeat
Masimo Corporation stock hits 52-week high at $175.91 - Investing.com
Masimo Corporation stock hits 52-week high at $175.91 By Investing.com - Investing.com Canada
Masimo (NASDAQ:MASI) Sees Large Volume IncreaseTime to Buy? - MarketBeat
Danaher to acquire Irvine-based Masimo - irvinestandard.com
Masimo (MASI) CFO exercises RSUs, retains shares after tax withholding - Stock Titan
Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders? – Company Announcement - Financial Times
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement - Yahoo Finance
Masimo Corporation $MASI Shares Purchased by Squarepoint Ops LLC - MarketBeat
Onex Canada Asset Management Inc. Has $4.12 Million Stake in Masimo Corporation $MASI - MarketBeat
Danaher Corp to acquire Masimo for $9.9B - respiratory-therapy.com
Politan-linked funds structure MASIMO (MASI) forward sales over 273,550 shares - Stock Titan
12,025 Shares in Masimo Corporation $MASI Bought by Quantitative Investment Management LLC - MarketBeat
Danaher Corp. Stock (ISIN: US2358511028) Slides Amid Masimo Acquisition Scrutiny and Conservative Gu - AD HOC NEWS
Danaher Corp Stock (DHR) Moved Down by 3.55% on Mar 12: Drivers Behind the Movement - TradingKey
MASI SEC FilingsMasimo Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Schroder Investment Management Group Has $48.12 Million Holdings in Masimo Corporation $MASI - MarketBeat
Masimo (MASI) Chief Commercial Officer granted 8,550 RSUs in new Form 4 - Stock Titan
Masimo (MASI) grants Chief Marketing Officer 6,128 RSUs vesting over four years - Stock Titan
Masimo (MASI) grants 5,985 restricted stock units to Chief HR Officer - Stock Titan
Masimo (MASI) awards EVP of Operations 6,840 restricted stock units - Stock Titan
Masimo (NASDAQ: MASI) CFO gets 17,671 RSUs vesting over 4 years - Stock Titan
[Form 4] MASIMO CORP Insider Trading Activity - Stock Titan
Finanzdaten der Masimo Corp-Aktie (MASI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Masimo Corp-Aktie (MASI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Young Micah W | EVP & Chief Financial Officer |
Mar 11 '26 |
Option Exercise |
0.00 |
873 |
0 |
26,127 |
| Szyman Catherine M. | CEO |
Feb 12 '26 |
Option Exercise |
132.96 |
11,141 |
1,481,307 |
11,141 |
| Sampath Anand | EVP, Ops & Clinical Research |
Jan 28 '26 |
Option Exercise |
37.84 |
30,000 |
1,135,200 |
59,589 |
| Sampath Anand | EVP, Ops & Clinical Research |
Jan 28 '26 |
Sale |
136.81 |
18,680 |
2,555,570 |
40,909 |
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):